FRATER RAZES Laboratories Illuminates Algeria’s Pharmaceutical Prowess at the 8th International Conference on Hospital Pharmacy and Oncology

A Legacy of Leadership in Algeria’s Pharmaceutical Industry

Founded by the visionary Dr. Abdelhamid Cherfaoui, FRATER RAZES Laboratories Group is a hallmark of Algeria’s pharmaceutical landscape. As one of the pioneers in the country’s medicine market, the laboratory has continuously redefined excellence, blending innovation with a steadfast commitment to autonomy and the superior quality of its products.

Its crowning achievement came with the production of anticoagulants derived from living cells, ending two decades of reliance on imports and propelling Algeria toward self-sufficiency in critical healthcare solutions. The laboratory’s groundbreaking contributions during the COVID-19 pandemic, particularly with the creation of the biological anticoagulant substitute “Vaginox,” underscored its unparalleled role in securing national healthcare during crises.

Strategic Leadership in Times of Crisis

Under the adept leadership of Salah Eddine Khaled, General Strategy Official, FRATER RAZES Laboratories became an indispensable partner in Algeria’s fight against COVID-19. Amid a global scarcity of medicines, the laboratory produced seven of the eight essential drugs used in the national treatment protocol, further cementing its role as a guardian of public health.

Highlighting its advanced production capabilities, the laboratory operates five specialized production poles, including injectable materials, technology for medical devices, and food supplements. These units boast remarkable outputs, such as an annual production of 50 million syringes and 50 million cans of dry materials, reflecting the facility’s alignment with international quality standards.

Adherence to World-Class Standards

FRATER RAZES Laboratories upholds rigorous quality control measures in compliance with ISO 9001:2015 standards, the International Council for Harmonisation (ICH), and leading pharmacopoeia from Europe, Britain, and the United States. The laboratory’s steadfast adherence to these benchmarks has earned it accreditations from Algeria’s National Agency for Pharmaceutical Products and the Ministry of Pharmaceutical Industry, affirming its position as a global player in pharmaceutical manufacturing.

With over 800 internal control procedures and state-of-the-art industrial tools imported from Northern Europe, the laboratory ensures each product meets the most stringent standards of reliability and efficacy.

Empowering Algeria’s Economic Diversification

FRATER RAZES plays a pivotal role in Algeria’s strategy to diversify exports and reduce reliance on hydrocarbons. Its pharmaceutical exports reach 10 African nations and three Arab countries, showcasing its contribution to regional healthcare development. This aligns with the government’s vision to promote sustainable industries and bolster Algeria’s position as a leader in medical innovation.

Minister of the Interior Brahim Merad, during an official ceremony, hailed the laboratory’s transformative impact on the healthcare and pharmaceutical sectors. Presenting investment certificates to FRATER RAZES, the Minister praised its achievements as a beacon of national pride. “FRATER RAZES embodies Algeria’s resolve to innovate, sustain, and excel in industries that secure the health and prosperity of our people,” Merad stated.

Sustainability and Community Welfare at the Core

The laboratory’s commitment to sustainability and community well-being extends beyond production. Director of Sales and Marketing Amira Ben Kara Moustafa highlighted the company’s eco-conscious practices, emphasizing its role as a steward of environmental preservation. “At FRATER RAZES, we prioritize sustainable solutions that balance environmental responsibility with groundbreaking pharmaceutical innovation,” she remarked.

A Promising Future of Innovation

As FRATER RAZES Laboratories continues to lead Algeria’s pharmaceutical renaissance, its unwavering dedication to innovation, adherence to global standards, and profound commitment to societal well-being ensure its legacy as a trailblazer in the field. The laboratory’s visionary leadership and groundbreaking achievements represent a source of inspiration, setting a benchmark for excellence across Algeria and beyond.

FRATER RAZES Laboratories is not merely a pharmaceutical leader—it is a symbol of Algeria’s ingenuity, resilience, and unyielding commitment to a healthier and more prosperous future.